These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33964944)

  • 1. Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
    Leon-Justel A; Morgado Garcia-Polavieja JI; Alvarez-Rios AI; Caro Fernandez FJ; Merino PAP; Galvez Rios E; Vazquez-Rico I; Diaz Fernandez JF
    Health Qual Life Outcomes; 2021 May; 19(1):142. PubMed ID: 33964944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of Sacubitril-Valsartan in Hospitalized Patients Who Have Heart Failure With Reduced Ejection Fraction.
    Gaziano TA; Fonarow GC; Velazquez EJ; Morrow DA; Braunwald E; Solomon SD
    JAMA Cardiol; 2020 Nov; 5(11):1236-1244. PubMed ID: 32785628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-based care for the specialized management of heart failure: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(17):1-42. PubMed ID: 23074521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telemonitoring patients with chronic heart failure. Results from a pilot study in the Veneto Region, Italy].
    Vittorii S; Zuin M; Paolini C; Manea S; Stopazzolo G; Bilato C
    G Ital Cardiol (Rome); 2023 Sep; 24(9):741-750. PubMed ID: 37642126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event.
    Butler J; Djatche LM; Sawhney B; Chakladar S; Yang L; Brady JE; Yang M
    Adv Ther; 2020 Sep; 37(9):4015-4032. PubMed ID: 32761552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of a postdischarge pharmaceutical care program vs regular follow-up in patients with heart failure.
    López Cabezas C; Falces Salvador C; Cubí Quadrada D; Arnau Bartés A; Ylla Boré M; Muro Perea N; Homs Peipoch E
    Farm Hosp; 2006; 30(6):328-42. PubMed ID: 17298190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
    Ledwidge M; Barry M; Cahill J; Ryan E; Maurer B; Ryder M; Travers B; Timmons L; McDonald K
    Eur J Heart Fail; 2003 Jun; 5(3):381-9. PubMed ID: 12798838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost effectiveness of REACH-HF and home-based cardiac rehabilitation compared with the usual medical care for heart failure with reduced ejection fraction: A decision model-based analysis.
    Taylor RS; Sadler S; Dalal HM; Warren FC; Jolly K; Davis RC; Doherty P; Miles J; Greaves C; Wingham J; Hillsdon M; Abraham C; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
    Eur J Prev Cardiol; 2019 Aug; 26(12):1252-1261. PubMed ID: 30884975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects and costs of home-based rehabilitation for heart failure with reduced ejection fraction: The REACH-HF multicentre randomized controlled trial.
    Dalal HM; Taylor RS; Jolly K; Davis RC; Doherty P; Miles J; van Lingen R; Warren FC; Green C; Wingham J; Greaves C; Sadler S; Hillsdon M; Abraham C; Britten N; Frost J; Singh S; Hayward C; Eyre V; Paul K; Lang CC; Smith K
    Eur J Prev Cardiol; 2019 Feb; 26(3):262-272. PubMed ID: 30304644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
    Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and healthcare utilisation of patients with heart failure in Spain.
    Escobar C; Varela L; Palacios B; Capel M; Sicras A; Sicras A; Hormigo A; Alcázar R; Manito N; Botana M
    BMC Health Serv Res; 2020 Oct; 20(1):964. PubMed ID: 33081776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacubitril/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis.
    Zacà V
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):597-605. PubMed ID: 30160656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Networking and data sharing reduces hospitalization cost of heart failure: the experience of GISC study.
    Pisanò F; Lorenzoni G; Sabato SS; Soriani N; Narraci O; Accogli M; Rosato C; de Paolis P; Folino F; Buja G; Tona F; Baldi I; Iliceto S; Gregori D;
    J Eval Clin Pract; 2015 Feb; 21(1):103-8. PubMed ID: 25266937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Remote Medication Monitoring System for Chronic Heart Failure Patients to Reduce Readmissions: A Two-Arm Randomized Pilot Study.
    Hale TM; Jethwani K; Kandola MS; Saldana F; Kvedar JC
    J Med Internet Res; 2016 Apr; 18(5):e91. PubMed ID: 27154462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuscan Chronic Care Model: a preliminary analysis].
    Barbato A; Meggiolaro A; Rossi L; Fioravanti C; Palermita F; La Torre G
    Ig Sanita Pubbl; 2015; 71(5):499-513. PubMed ID: 26722827
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.